SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001439222-21-000002
Filing Date
2021-01-25
Accepted
2021-01-25 16:28:08
Documents
2
Period of Report
2021-01-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_161160995336032.html 3  
1 FORM 3 wf-form3_161160995336032.xml 3 13742
2 POA D MILES ex-24.htm EX-24 4257
  Complete submission text file 0001439222-21-000002.txt   19450
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Issuer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AGIOS PHARMACEUTICALS, INC. 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Miles Darrin (Reporting) CIK: 0001840076 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36014 | Film No.: 21549909